We are live on ! Find out more
First Manhattan

First Manhattan Portfolio holdings

AUM $36.1B
1-Year Est. Return 11.5%
This Fund
S&P 500
This Quarter Est. Return
+1.82%
1 Year Est. Return
+11.5%
3 Year Est. Return
+74.65%
5 Year Est. Return
+103.66%
10 Year Est. Return
+354.63%
AUM
$34.1B
AUM Growth
+$366M
Cap. Flow
+$84.4M
Cap. Flow %
0.25%
Top 10 Hldgs %
59.17%
Holding
723
New
41
Increased
189
Reduced
269
Closed
43

Top Buys

Rank Stock Value
1
ASML icon
ASML
ASML
+$118M
2
BRK.A icon
Berkshire Hathaway Class A
BRK.A
+$77.6M
3
UNP icon
Union Pacific
UNP
+$57.3M
4
NVDA icon
NVIDIA
NVDA
+$47.6M
5
AMAT icon
Applied Materials
AMAT
+$45.7M

Top Sells

Rank Stock Value
1
MKL icon
Markel Group
MKL
+$70.6M
2
AZPN
Aspen Technology Inc
AZPN
+$53.7M
3
KKR icon
KKR & Co
KKR
+$44M
4
AAPL icon
Apple
AAPL
+$33.7M
5
CSW
CSW Industrials
CSW
+$28.2M

Sector Composition

Rank Sector Weight
1 Financials 44.82%
2 Technology 21.62%
3 Consumer Discretionary 7.18%
4 Communication Services 6.65%
5 Healthcare 6.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TGB
651
Trekor Metals
TGB
$2.56B
$194K ﹤0.01%
100,000
NOV icon
652
NOV
NOV
$7.45B
$190K ﹤0.01%
12,995
-786
-6% -$12.3K
KW
653
DELISTED
Kennedy-Wilson Holdings
KW
$187K ﹤0.01%
18,500
USCB icon
654
USCB Financial Holdings
USCB
$396M
$178K ﹤0.01%
10,000
ALDX icon
655
Aldeyra Therapeutics
ALDX
$91.7M
$173K ﹤0.01%
34,745
SBRA icon
656
Sabra Healthcare REIT
SBRA
$5.64B
$173K ﹤0.01%
10,000
UG icon
657
United-Guardian
UG
$35M
$163K ﹤0.01%
17,062
MATV icon
658
Mativ Holdings
MATV
$448M
$158K ﹤0.01%
14,506
-500
-3% -$6.97K
TK icon
659
Teekay
TK
$975M
$157K ﹤0.01%
+22,686
New +$175K
ROIV icon
660
Roivant Sciences
ROIV
$25.2B
$143K ﹤0.01%
12,100
+200
+2% +$2.37K
WNEB icon
661
Western New England Bancorp
WNEB
$287M
$143K ﹤0.01%
15,518
EEX
662
DELISTED
Emerald Holding
EEX
$122K ﹤0.01%
25,338
+3,575
+16% +$16.4K
VLN icon
663
Valens Semiconductor
VLN
$176M
$113K ﹤0.01%
43,458
KLTR icon
664
Kaltura
KLTR
$211M
$110K ﹤0.01%
50,000
CERS icon
665
Cerus
CERS
$587M
$87.8K ﹤0.01%
57,000
OPK icon
666
Opko Health
OPK
$921M
$76.1K ﹤0.01%
51,750
IMRX icon
667
Immuneering
IMRX
$279M
$71.1K ﹤0.01%
+32,325
New +$67K
EGY icon
668
Vaalco Energy
EGY
$594M
$49.5K ﹤0.01%
+11,337
New +$60.3K
TSHA icon
669
Taysha Gene Therapies
TSHA
$1.59B
$49.3K ﹤0.01%
+28,500
New +$59.1K
ABUS icon
670
Arbutus Biopharma
ABUS
$865M
$45.8K ﹤0.01%
14,000
ORIO
671
Orion Digital Corp
ORIO
$15.4M
$34.3K ﹤0.01%
26,400
OVID icon
672
Ovid Therapeutics
OVID
$435M
$24.3K ﹤0.01%
26,000
GROV icon
673
Grove Collaborative
GROV
$45M
$16.2K ﹤0.01%
11,662
OTLY
674
Oatly Group
OTLY
$417M
$13.3K ﹤0.01%
1,000
LUCD icon
675
Lucid Diagnostics
LUCD
$173M
$10.3K ﹤0.01%
12,600

Similar funds

First Manhattan's Q4 2024 Portfolio in Review

As of Q4 2024, First Manhattan held 723 positions worth $34.1B, up 1.1% from $33.7B the previous quarter. Its ten largest holdings account for 59% of the portfolio.

First Manhattan's Q4 2024 filing shows 41 new, 189 increased, 269 reduced and 43 closed positions. Its largest new stake was Kinsale Capital Group: 40,140 shares worth $18.7M. The largest sale was Markel Group, an estimated $70.6M.

By sector, the portfolio is most concentrated in Financials at 45% of assets, up from 45% a quarter earlier, followed by Technology and Consumer Discretionary.

  • First Manhattan's largest Q4 2024 buy was Kinsale Capital Group: 40,140 shares worth $18.7M.
  • First Manhattan added most to ASML in Q4 2024, an estimated $118M increase.
  • First Manhattan's biggest Q4 2024 reduction was Markel Group, cutting an estimated $70.6M.
  • First Manhattan fully exited Wells Fargo 7.5% Non Cumv Perp Conv in Q4 2024, selling an estimated $9.31M.
  • First Manhattan's ten largest holdings make up 59% of its $34.1B portfolio in Q4 2024.
  • First Manhattan opened 41 new positions and closed 43 in Q4 2024.
  • First Manhattan's portfolio value rose 1.1% quarter-over-quarter to $34.1B.

Based on First Manhattan's 13F filing for Q4 2024, filed 14 Feb 2025.